TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

196.90$ +0.5% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Revolution Medicines Inc (RVMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 86.1% of the shares are freely tradable; institutional investors hold 95.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 95.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.9%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 86.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 214Mio.

Largest Shareholders

Institutions

Institutions RVMD
Name Stake (%) Shares Change (%) Date
Farallon Capital Management, L.L.C. 6.35 13,604,796 -6.7 03/31/2026
BlackRock Inc 5.23 11,212,706 +25.6 03/31/2026
Darwin Global Management, Ltd. 4.96 10,629,822 +380.8 06/30/2026
HHG PLC 4.56 9,766,496 -20.6 03/31/2026
Baker Bros Advisors LP 4.46 9,555,357 +1.1 03/31/2026
FMR Inc 3.95 8,464,314 -1.4 03/31/2026
Vanguard Capital Management, LLC 3.90 8,362,284 +0.0 03/31/2026
Nextech Invest, Ltd. 3.55 7,601,087 +0.0 06/30/2026
Vanguard Portfolio Management, LLC 3.50 7,502,623 +0.0 03/31/2026

Funds

Funds RVMD
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.00 6,432,190 +0.3 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings RVMD
Person Role Shares Value As of Type
Goldsmith Mark A See Remarks 328,880 64,756,472 $ Aug 21, 2026 both
Kelsey Stephen Michael See Remarks 291,876 57,470,384 $ Sep 11, 2026 direct
Cislini Jeff General Counsel 55,907 11,008,088 $ Aug 21, 2026 direct
Mancini Anthony See Remarks 43,890 8,641,941 $ Sep 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 3,270 205.81 672,991
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 4,995 204.84 1,023,189
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 17,949 203.87 3,659,309
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 18,869 203.06 3,831,550
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 21,447 201.75 4,326,947
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 13,368 200.78 2,683,986
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 11,833 200.11 2,367,955
Sep 11, 2026 Kelsey Stephen Michael See Remarks Sell 800 198.55 158,840
Sep 11, 2026 Kelsey Stephen Michael See Remarks Other 40,031 40.74 1,630,863
Sep 11, 2026 Kelsey Stephen Michael See Remarks Other 52,500 42.45 2,228,625
Sep 10, 2026 Mancini Anthony See Remarks Sell 300 207.17 62,152
Sep 10, 2026 Mancini Anthony See Remarks Sell 1,179 206.10 242,991
Sep 10, 2026 Mancini Anthony See Remarks Sell 2,420 205.05 496,224
Sep 10, 2026 Mancini Anthony See Remarks Sell 5,530 204.14 1,128,870
Sep 10, 2026 Mancini Anthony See Remarks Sell 6,019 203.28 1,223,569
Sep 10, 2026 Mancini Anthony See Remarks Other 9,363 33.62 314,784
Sep 8, 2026 Kim Lorence H. Director Sell 371 212.27 78,752
Sep 8, 2026 Kim Lorence H. Director Sell 3,844 211.36 812,463
Sep 8, 2026 Kim Lorence H. Director Sell 4,730 210.50 995,678
Sep 8, 2026 Kim Lorence H. Director Sell 2,853 209.56 597,875
Sep 8, 2026 Kim Lorence H. Director Sell 3,587 208.55 748,081
Sep 8, 2026 Kim Lorence H. Director Sell 999 207.33 207,125
Sep 8, 2026 Kim Lorence H. Director Sell 706 206.60 145,863
Aug 31, 2026 Kim Lorence H. Director Sell 625 206.15 128,846
Aug 31, 2026 Kim Lorence H. Director Sell 2,128 205.19 436,640
Aug 31, 2026 Kim Lorence H. Director Sell 7,271 204.35 1,485,830
Aug 31, 2026 Kim Lorence H. Director Sell 26,160 203.55 5,324,824
Aug 31, 2026 Kim Lorence H. Director Sell 12,919 202.48 2,615,864
Aug 31, 2026 Kim Lorence H. Director Sell 6,597 201.47 1,329,117
Aug 31, 2026 Kim Lorence H. Director Sell 300 200.56 60,168
Aug 21, 2026 Cislini Jeff General Counsel Sell 3,314 212.06 702,761
Aug 21, 2026 Cislini Jeff General Counsel Sell 4,500 211.34 951,038
Aug 21, 2026 Cislini Jeff General Counsel Sell 2,540 210.26 534,072
Aug 21, 2026 Cislini Jeff General Counsel Sell 25,817 209.25 5,402,200
Aug 21, 2026 Cislini Jeff General Counsel Sell 17,323 208.37 3,609,573
Aug 21, 2026 Cislini Jeff General Counsel Sell 3,400 207.24 704,603
Aug 21, 2026 Cislini Jeff General Counsel Other 26,600 21.61 574,826
Aug 21, 2026 Cislini Jeff General Counsel Other 29,680 18.56 550,861
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 229 211.46 48,425
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 126 212.06 26,720
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 1,405 209.27 294,019
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 937 208.36 195,234
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 177 207.25 36,684
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 127 212.06 26,932
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 245 211.47 51,809
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 136 210.40 28,615
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 1,351 209.28 282,739
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 951 208.36 198,155
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 190 207.25 39,377
Aug 21, 2026 Goldsmith Mark A See Remarks Sell 3,621 212.08 767,933

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?